Entyre
PrivateLast Round
Series A
Extension
Jun 23, 2023
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Entyre operates in Healthcare & Life Sciences and is based in Berlin. Its latest recorded funding round was a Series A Extension round in June 2023.
Entyre is a health-tech company that provides a preventive healthcare platform using proprietary data and algorithms to improve outpatient care and support family caregivers.
Sector
Healthcare & Life Sciences
Verticals
Patient Engagement, Vertical SaaS, E-commerce
Business Model
B2C
Customer Profile
Services & Consulting, Hardware Sales, Subscription SaaS
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Entyre Comparables
Compare Entyre with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Kenbi | 77% | |
| INQbaker | 74% | |
| ucura Deutschland GmbH | 71% |
For institutional investors. Book with your work email.
Entyre Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Jun 23, 2023 | ||||
| Series A | Jan 11, 2022 | ||||
| Pre Seed | Jul 23, 2020 |
For institutional investors. Book with your work email.
Entyre Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| HV Capital | VC Round, Series A |
| Rheingau Founders | Seed, Pre Seed |
| SwissHealth Ventures | VC Round, Series A |
| EquityPitcher Ventures | VC Round, Series A Extension, Series A |
| Redstone VC | Series A |
| Heal Capital | VC Round, Pre Seed, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 14, 2026
Monthly visitors increased 32% MoM.
- Jul 1, 2026
Launched services in Maine, starting with a 'launch phase'.
For institutional investors. Book with your work email.
Entyre Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Entyre's valuation, stock price, and market status.
Is Entyre a public or private company?
Entyre is a private company.
What is the current stock price of Entyre?
Entyre is a private company, so its shares have no public market price. Caplight tracks Entyre's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Entyre worth (valuation)?
Valuation information for Entyre is not publicly available.
Can I buy Entyre stock?
Entyre shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Entyre's last funding round?
Entyre's most recent funding round was Series A Extension on June 23, 2023.
Who are the main investors in Entyre?
Key investors in Entyre include HV Capital, Rheingau Founders, SwissHealth Ventures, EquityPitcher Ventures, Redstone VC.
Will Entyre IPO soon?
No public IPO plans have been announced for Entyre.
How can I track Entyre secondary market activity?
Caplight tracks bids, offers, and trades in Entyre's shares on secondary markets.